Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs Propofol on Neuromuscular Strength
NCT05615025Phase 3Completed
- Sponsor
- CHU Brugmann
- Start
- Jan 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sevoflurane in general anesthesia (2 arms), sponsored by CHU Brugmann. Primary endpoints: Maximum force at the adductor pollicis at 3 hours, Maximum speed of contraction at the adductor pollicis at 3 hours and 1 more. Started Jan 2023; status: completed.
02
Drugs
sevoflurane
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT05615025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05615025.